Hydroxocobalamin 5 g IV for Cyanide Poisoning: What Clinicians and Curious Minds Need to Know
The Situation That Demands a Fast Answer
Cyanide poisoning doesn't give you a lot of time. But by the time someone presents with altered mental status, cardiovascular collapse, or the classic bitter almond smell that not everyone can even detect, the clock is already running. And in that moment, the team reaching for a treatment needs something that works quickly, reliably, and with a manageable side effect profile. That's where hydroxocobalamin 5 g IV comes in. It's not the oldest antidote on the shelf, and it's not the most glamorous. But in real-world toxicology, it has earned a reputation as one of the most practical tools we have Less friction, more output..
So what makes this particular formulation and dose so important? Let's break it down the way a clinician or a curious reader would actually want to understand it.
What Is Hydroxocobalamin 5 g IV
Hydroxocobalamin is a form of vitamin B12 — specifically, a cobalamin that the body can convert into the active coenzymes it needs for DNA synthesis and nervous system function. In its pharmaceutical form, it's a dark red crystalline powder that dissolves into a strikingly red solution when reconstituted. That color matters more than most people realize, and we'll get to why.
When we talk about hydroxocobalamin 5 g IV, we're referring to a single intravenous dose of 5 grams, delivered directly into the bloodstream. This is the standard adult dose used in suspected or confirmed cyanide poisoning, typically administered as a slow infusion over 15 minutes. The 5 g dose is not arbitrary — it's calibrated to bind a lethal or near-lethal burden of cyanide ions in the body.
The drug goes by several names depending on the market and the formulation. In the United States, the injectable product most commonly associated with this use is sold under the brand name Cyanokit, though compounding pharmacies and hospital pharmacies may also prepare it from bulk hydroxocobalamin hydrochloride. Regardless of the source, the active molecule is the same That's the whole idea..
Why Hydroxocobalamin Is Used for Cyanide Poisoning
Cyanide kills by shutting down cellular respiration. Cells can still have oxygen delivered to them, but they can't use it. Plus, it binds to cytochrome c oxidase in the mitochondria — the enzyme complex that allows cells to use oxygen — and essentially locks the door. The result is a kind of histotoxic hypoxia: the tissues are suffocating at the molecular level even though the lungs and heart may still be working.
The Problem with Older Antidotes
Before hydroxocobalamin entered widespread use, the mainstays of cyanide antidote therapy were the cyanide antidote kit containing amyl nitrite, sodium nitrite, and sodium thiosulfate. Sodium nitrite, for example, works by inducing methemoglobinemia — it forces hemoglobin into a form that preferentially binds cyanide, pulling it away from cytochrome c oxidase. Also, that kit still has a role, but it comes with significant drawbacks. The problem is that methemoglobinemia itself can be dangerous, especially in patients who already have compromised oxygen delivery due to smoke inhalation or concurrent anemia Turns out it matters..
Hydroxocobalamin sidesteps that problem almost entirely. Instead of manipulating hemoglobin into a different state, it grabs cyanide directly and forms cyanocobalamin — which is essentially vitamin B12. The body can then clear that safely through the kidneys.
Where Hydroxocobalamin Fits in Practice
In modern toxicology, hydroxocobalamin is increasingly the first-line antidote for cyanide poisoning, particularly in smoke inhalation scenarios where the patient may also have carbon monoxide exposure and compromised oxygenation. The fact that it doesn't worsen oxygen delivery makes it uniquely suited for these complex cases.
Easier said than done, but still worth knowing.
Emergency departments, burn units, and hazardous materials teams have all adopted it as a go-to option. And the 5 g IV dose has become the standard protocol in most institutional guidelines and poison control recommendations Small thing, real impact. But it adds up..
How Hydroxocobalamin Works Against Cyanide
The Chemistry Simplified
Here's the elegant part. Hydroxocobalamin has a strong affinity for cyanide ions. When the two meet in the bloodstream, hydroxocobalamin literally grabs the cyanide and holds onto it, forming cyanocobalamin. That reaction is fast — we're talking seconds to minutes — and it effectively neutralizes the cyanide before it can do further damage to the mitochondrial machinery.
Think of hydroxocobalamin as a molecular sponge. On the flip side, it soaks up cyanide ions and converts them into a compound the body already knows how to handle. The cyanocobalamin that forms is water-soluble and gets filtered out by the kidneys over the next several hours That's the part that actually makes a difference..
The Dosing: Why 5 Grams
The 5 g dose isn't a guess. On top of that, it's based on the pharmacology of the cyanide-hydroxocobalamin binding reaction. On top of that, each gram of hydroxocobalamin can bind approximately 1 gram of cyanide ion (as cyanide, not as cyanide-containing compounds). That said, a lethal dose of cyanide in humans is estimated to be around 1 to 3 mg per kilogram of body weight, so a 70 kg adult could have a potentially lethal burden of 70 to 210 mg of cyanide. The 5 g dose provides a substantial molar excess of hydroxocobalamin, ensuring that even a heavy cyanide load gets neutralized.
In practice, clinicians may repeat the dose if the patient doesn't respond adequately or if re-exposure is suspected. Some protocols allow for a second 5 g infusion, though this is guided by clinical response and laboratory confirmation when available Nothing fancy..
How It's Administered
Hydroxocobalamin 5 g IV is typically administered as a slow intravenous infusion over 15 minutes. The reconstituted solution is delivered through a dedicated IV line, and the infusion rate should not be rushed. Rapid injection can cause a sudden drop in blood pressure, which is one of the main side effects we'll discuss shortly.
The drug comes as a lyophilized powder that must be reconstituted with sterile water for injection or a compatible diluent before administration. Once reconstituted, the solution is a deep red color — which is actually useful in practice because it confirms that the correct drug is being infused.
What to Expect During Infusion
Most patients tolerate the infusion well, though some will experience transient side effects that resolve on their own. The clinical team should monitor blood pressure, heart rate, and oxygen saturation throughout the infusion. If
Monitoring and Management of Infusion‑Related Reactions
During the 15‑minute infusion and for the next few hours, the clinical team should keep a close eye on hemodynamic stability and any early warning signs of adverse reactions. Here's the thing — the most frequently reported infusion‑related event is hypotension, often accompanied by a mild bradycardia. In most cases the drop in blood pressure is transient and responds to a small fluid bolus or, if necessary, a short‑acting vasopressor such as phenylephrine.
You'll probably want to bookmark this section.
Other common but benign effects include flushing, a pruritic rash, and a metallic taste that patients may describe as “metallic after‑taste.” The infusion also causes a characteristic red discoloration of the urine and, occasionally, red‑tinged sweat—both are visual confirmations that the drug is circulating.
A less obvious but clinically relevant finding is hyperuricemia. In practice, hydroxocobalamin can displace uric acid from its binding proteins, leading to a modest rise in serum uric acid levels. While usually self‑limited, this elevation deserves attention in patients with pre‑existing gout, hyperuricemia, or impaired renal excretion.
Because the final product—cyanocobalamin—is eliminated unchanged by the kidneys, renal function
renal function should be assessed before and after therapy, particularly in patients with chronic kidney disease or acute renal insufficiency. Because hydroxocobalamin is converted to cyanocobalamin, which is cleared unchanged by glomerular filtration, a reduced creatinine clearance can prolong the plasma half‑life of the metabolite and increase the risk of accumulation‑related effects such as sustained hyperuricemia or prolonged urine discoloration. Here's the thing — in practice, if the estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1. 73 m², clinicians often consider administering the standard 5 g dose but extend the observation period and check serum uric acid and renal panels at 2‑, 4‑, and 6‑hour intervals post‑infusion. No formal dose reduction is mandated by the drug’s labeling, yet many toxicology experts advise a cautious approach—using the lower end of the dosing range (e.Day to day, g. , a single 5 g bolus) and reserving a repeat infusion only for clear evidence of ongoing cyanide toxicity or re‑exposure.
Special populations warrant additional consideration. In practice, pediatric dosing is weight‑based, typically 70 mg/kg (up to a maximum of 5 g) administered over 15 minutes, with the same infusion precautions applied. All the same, fetal monitoring is advisable when maternal cyanide exposure is severe. But in pregnant patients, hydroxocobalamin is classified as pregnancy category B; animal studies have not demonstrated teratogenicity, and the drug’s mechanism—binding cyanide to form vitamin B12—does not interfere with fetal development. Neonates and infants may require slower infusion rates to mitigate hypotension, given their limited cardiovascular reserve Worth keeping that in mind. Practical, not theoretical..
Drug interactions are minimal because hydroxocobalamin does not rely on hepatic metabolism. That said, concomitant use of agents that affect uric acid handling (e.The drug’s intense red color can interfere with certain spectrophotometric assays (e.g.That's why g. Which means , allopurinol, uricosurics) may exaggerate the transient hyperuricemia observed after infusion; clinicians should be aware of this when managing patients with gout or undergoing chemotherapy that predisposes to tumor lysis syndrome. , some bilirubin or creatinine methods), potentially leading to spurious laboratory results; therefore, timing blood draws before infusion or using alternative assays is recommended.
Storage and stability are straightforward: the lyophilized powder remains stable at controlled room temperature (20‑25 °C) until reconstitution. Once mixed with sterile water, the solution should be used immediately; if delayed, it can be kept at room temperature for no more than 4 hours or refrigerated (2‑8 °C) for up to 24 hours, protected from light to prevent photodegradation.
In a nutshell, hydroxocobalamin 5 g IV offers a rapid, mechanistically sound antidote for acute cyanide poisoning, converting the toxic ion into a harmless vitamin B12 analogue. That said, administration as a slow 15‑minute infusion minimizes hemodynamic instability, while vigilant monitoring of blood pressure, uric acid levels, and renal function mitigates the most common adverse effects. Now, dose repetition is guided by clinical response and, when available, laboratory confirmation of cyanide clearance. And special attention to renal impairment, pregnancy, pediatric dosing, and potential assay interference ensures safe and effective use across diverse patient populations. When integrated into a comprehensive toxicology protocol—including airway support, oxygenation, and consideration of adjunctive agents such as sodium thiosulfate—hydroxocobalamin remains a cornerstone therapy that markedly improves outcomes in cyanide‑exposed individuals That's the part that actually makes a difference. Worth knowing..
